下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEGSK-J4 hydrochlorideCat. No.: HY-15648FCAS No.: 1797983-09-5分式: CHClNO分量: 453.96作靶點: Histone Demethylase作通路: Epigenetics儲存式: Please store the product under the recommended conditions inthe COA.溶解性數(shù)據(jù)體外實驗 DMSO : 125 mg/mL (275.35
2、mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 2.2028 mL 11.0142 mL 22.0284 mL5 mM 0.4406 mL 2.2028 mL 4.4057 mL10 mM 0.2203 mL 1.1014 mL 2.2028 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。體內(nèi)實驗 請根據(jù)您的實驗動物和給藥式選擇適當(dāng)?shù)娜芙獍?,配制前請先配制澄的儲備液,再依次添加助溶?為保證實驗結(jié)果的可靠性,體內(nèi)實驗的作液,建議您現(xiàn)現(xiàn)配,當(dāng)天使;澄的儲備液
3、可以根據(jù)儲存條件,適當(dāng)保存;以下溶劑前的百分指該溶劑在您配制終溶液中的體積占):1. 請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.08 mg/mL (4.58 mM); Clear solution2. 請依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.08 mg/mL (4.58 mM); Clear solutionBIOLOGICAL ACTIVITY物活性GSK-J4 hydrochloride種有效的 H3K27me3/me2
4、 去甲化酶 JMJD3/KDM6B 和 UTX/KDM6A 雙抑制劑,1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEIC50 分別為 8.6 M 和 6.6 M。GSK-J4 hydrochloride 抑制 LPS 誘導(dǎo)的原代巨噬細(xì)胞產(chǎn) TNF-,IC50值為 9 M。GSK-J4 hydrochlorideGSK-J1 的細(xì)胞通透性前藥。IC50 & Target IC50: 8.6 M (JMJD3/KDM6B), 6.6 M (UTX/KDM6A) 6體外研究 GSK-J4 Hydrochloride has cellular act
5、ivity in Flag-JMJD3-transfected HeLa cells, in which GSK-J4 preventsthe JMJD3-induced loss of nuclear H3K27me3 immunostaining. Administration of GSK-J4 increases totalnuclear H3K27me3 levels in untransfected cells. GSK-J4 significantly reduces the expression of 16 of 34LPS-driven cytokines, includin
6、g tumour-necrosis factor- (TNF-) 1.GSK-J4 Hydrochloride (5 M; 48 hours) causes a more than 3-fold increase in mouse podocyte H3K27me3content. H3K27me3 levels in cultured podocytes, GSK-J4 reduces Jagged-1 mRNA and Jagged-1 proteinlevels. Correspondingly, when exposed podocytes to the inducer of dedi
7、fferentiation TGF-1, pretreatmentwith GSK-J4 preventes both the increase in intracellular N1-ICD levels and the increase in -SMA and thedecrease in podocin mRNA levels 2.GSK-J4 Hydrochloride (10, 25 nM) acts upon DCs promoting the differentiation of Treg cells, improving Tregstability and suppressiv
8、e capacities, without affecting the differentiation of Th1 and Th17 cells 3.GSK-J4 Hydrochloride inhibits JMJD3 expression that is induced by TGF-1 4.GSK-J4 Hydrochloride inhibits H3K4 demethylation at Xist, Nodal, and HoxC13 in female embryonic stemcells 5.體內(nèi)研究 GSK-J4 Hydrochloride (10 mg/kg; i.p.;
9、 thrice-weekly for 10 weeks) attenuates the development of kidneydisease in diabetic mice 2.GSK-J4 Hydrochloride (0.5 mg/kg, i.p.) significantly reduces the severity and delays the onset of the diseaseof the mouse model of experimental autoimmune encephalomyelitis 3.Animal Model: Eight-week-old male
10、 db/m and db/db mice on a BKS background 2Dosage: 10 mg/kgAdministration: i.p.; thrice-weekly for 10 weeksResult: Attenuated the development of kidney disease in diabetic mice. J Clin Invest. 2018 Jan 2;128(1):483-499. Biochem J. 2019 Jun 26;476(12):1741-1751. IUBMB Life. 2019 Jun 26. Oncol Rep. 201
11、9 May;41(5):2667-2678. Patent. US20180263995A1.See more customer validations on HYPERLINK / www.MedChemEREFERENCES2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE1. Kruidenier L, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012Au
12、g 16;488(7411):404-8.2. Majumder S, et al. Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease. J Clin Invest. 2018 Jan2;128(1):483-499.3. Donas C, et al. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs.
13、J Autoimmun. 2016 Dec;75:105-117.4. Yapp C, et al. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis. Arthritis Res Ther.2016 Jul 7;18(1):1585. Kamikawa YF, et al. Histone demethylation maintains Prdm14 and Tsix expression and represses xIst in embryonic stem cells. PLoSOne. 2015 May 20;10(5):e01256266. Heinemann B, et al. Inhibition of demethylases by GSK-J1/J4. Nature. 2014 Oct 2;514(7520):E1-2
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 二零二五年度環(huán)保材料印刷委托協(xié)議范本3篇
- 2025版牙齒矯正教育培訓(xùn)機構(gòu)合作合同3篇
- 二零二五年度個人掛靠公司教育培訓(xùn)合作協(xié)議3篇
- 二零二五版私人學(xué)校物業(yè)設(shè)施租賃及管理合同3篇
- 機械設(shè)備行業(yè)員工需求
- 服裝行業(yè)生產(chǎn)工藝安全
- 藥學(xué)科護士協(xié)助藥劑配制
- 二零二五年度個人股權(quán)轉(zhuǎn)讓代持協(xié)議書(股權(quán)代持與退出機制)16篇
- 二零二五年度行政合同訂立流程與模板指南3篇
- 二零二五年度婚禮視頻拍攝制作合同2篇
- 八年級上冊英語完形填空、閱讀理解100題含參考答案
- 八年級物理下冊功率課件
- DBJ51-T 188-2022 預(yù)拌流態(tài)固化土工程應(yīng)用技術(shù)標(biāo)準(zhǔn)
- 《長津湖》電影賞析PPT
- 銷售禮儀培訓(xùn)PPT
- 滑雪運動介紹
- 最新滋補類中藥的用藥保健主題講座課件
- 大數(shù)據(jù)和人工智能知識考試題庫600題(含答案)
- 2021譯林版高中英語選擇性必修一單詞表
- 機器人控制課件
- 招聘會突發(fā)事件應(yīng)急預(yù)案(通用6篇)
評論
0/150
提交評論